- Home
- ORIC vs STK Comparison
ORIC vs STK Comparison
Compare ORIC & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- STK
- Stock Information
- Founded
- ORIC 2014
- STK 2009
- Country
- ORIC United States
- STK United States
- Employees
- ORIC N/A
- STK N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- STK Investment Managers
- Sector
- ORIC Health Care
- STK Finance
- Exchange
- ORIC Nasdaq
- STK Nasdaq
- Market Cap
- ORIC 362.9M
- STK 434.6M
- IPO Year
- ORIC 2020
- STK N/A
- Fundamental
- Price
- ORIC $11.10
- STK $30.85
- Analyst Decision
- ORIC Strong Buy
- STK
- Analyst Count
- ORIC 9
- STK 0
- Target Price
- ORIC $18.29
- STK N/A
- AVG Volume (30 Days)
- ORIC 964.9K
- STK 38.2K
- Earning Date
- ORIC 08-11-2025
- STK 01-01-0001
- Dividend Yield
- ORIC N/A
- STK 6.60%
- EPS Growth
- ORIC N/A
- STK N/A
- EPS
- ORIC N/A
- STK N/A
- Revenue
- ORIC N/A
- STK N/A
- Revenue This Year
- ORIC N/A
- STK N/A
- Revenue Next Year
- ORIC N/A
- STK N/A
- P/E Ratio
- ORIC N/A
- STK N/A
- Revenue Growth
- ORIC N/A
- STK N/A
- 52 Week Low
- ORIC $3.90
- STK $24.95
- 52 Week High
- ORIC $14.67
- STK $34.31
- Technical
- Relative Strength Index (RSI)
- ORIC 66.82
- STK 70.83
- Support Level
- ORIC $10.42
- STK $30.60
- Resistance Level
- ORIC $11.50
- STK $31.00
- Average True Range (ATR)
- ORIC 0.62
- STK 0.39
- MACD
- ORIC -0.03
- STK 0.07
- Stochastic Oscillator
- ORIC 83.30
- STK 92.55
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.